Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 5/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | MAOA | P21397 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | GSTP1 | P09211 | 2/20 | 0.57 |
| ▸ | PPARG | P37231 | 1/20 | 0.54 |
| ▸ | PPARD | Q03181 | 1/20 | 0.54 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.51 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | MGAM | O43451 | 1/20 | 0.49 |
| ▸ | SI | P14410 | 1/20 | 0.49 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12533272 | 0.86 | MAOB (0.65) | MAOBGAAMAPTMAOARAB9A | |
| SCHEMBL10017580 | 0.84 | MAOB (0.64) | MAOBGAAMAPTMAOARAB9A | |
| SCHEMBL12220476 | 0.84 | PARP10 (0.50) | MAOBGAAMAPTMAOARAB9A | |
| SCHEMBL10017577 | 0.83 | RXRA (0.47) | MAOBGAAMAPTMAOARAB9A | |
| SCHEMBL18027651 | 0.82 | GSTP1 (0.57) | MAOBGAAMAPTMAOARAB9A | |
| SCHEMBL5045790 | 0.81 | MAOB (0.89) | MAOBGAAMAPTMAOARAB9A | |
| SCHEMBL3791194 | 0.81 | MAOB (0.68) | MAOBGAAMAPTMAOARAB9A | |
| SCHEMBL12241389 | 0.81 | MAOB (0.47) | MAOBGAAMAPTMAOARAB9A | |
| SCHEMBL23483029 | 0.81 | LMNA (0.69) | MAOBGAAMAPTMAOARAB9A | |
| SCHEMBL1096817 | 0.81 | LMNA (0.69) | MAOBGAAMAPTMAOARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180153830-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2018-06-07 | — | — | US | disclosed |
| US-20180153830-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2018-06-07 | — | — | US | disclosed |
| US-20170027890-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2017-02-02 | — | — | US | disclosed |
| US-20170027890-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2017-02-02 | — | — | US | disclosed |
| US-20170027890-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2017-02-02 | — | — | US | disclosed |
| US-9456998-B2 | Selective inhibitors of undifferentiated cells | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2016-10-04 | — | — | US | disclosed |
| US-9456998-B2 | Selective inhibitors of undifferentiated cells | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2016-10-04 | — | — | US | disclosed |
| US-9456998-B2 | Selective inhibitors of undifferentiated cells | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2016-10-04 | — | — | US | disclosed |
| US-20150148359-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2015-05-28 | — | — | US | disclosed |
| US-20150148359-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2015-05-28 | — | — | US | disclosed |
| US-20150148359-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2015-05-28 | — | — | US | disclosed |
| WO-2013175474-A2 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2013-11-28 | — | — | WO | disclosed |
| EP-0663391-B1 | Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls | HOFFMANN LA ROCHE (CH) | 1997-04-09 | — | — | EP | disclosed |
| US-5521160-A | COMPOUNDS FOR TREATMENT OF ATHERIOSCLEROSIS IN BLOOD VESSELS AND PREVENTION OF RESTENOSIS AFTER ANGIOPLASTY | HOFFMANN-LA ROCHE INC. (US) | 1996-05-28 | — | — | US | disclosed |
| EP-0663391-A1 | Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls | F. HOFFMANN-LA ROCHE AG (CH) | 1995-07-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180153830-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | MCL1, MKI67, SCD | MAOB 3632/4885GAA 918/4885MAPT 4089/4885 |
| US-20170027890-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | MCL1, MKI67, SCD | MAOB 3632/4885GAA 918/4885MAPT 4089/4885 |
| US-20150148359-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | MCL1, MKI67, SCD | MAOB 3632/4885GAA 918/4885MAPT 4089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.